IBDEI0N5 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10798,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10798,1,3,0)
 ;;=3^Coagulation Profile,Abnormal
 ;;^UTILITY(U,$J,358.3,10798,1,4,0)
 ;;=4^R79.1
 ;;^UTILITY(U,$J,358.3,10798,2)
 ;;=^5019591
 ;;^UTILITY(U,$J,358.3,10799,0)
 ;;=R79.82^^47^521^24
 ;;^UTILITY(U,$J,358.3,10799,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10799,1,3,0)
 ;;=3^C-Reactive Protein,Elevated
 ;;^UTILITY(U,$J,358.3,10799,1,4,0)
 ;;=4^R79.82
 ;;^UTILITY(U,$J,358.3,10799,2)
 ;;=^331570
 ;;^UTILITY(U,$J,358.3,10800,0)
 ;;=D75.9^^47^521^25
 ;;^UTILITY(U,$J,358.3,10800,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10800,1,3,0)
 ;;=3^Blood/Blood-Forming Organ Disease,Unspec
 ;;^UTILITY(U,$J,358.3,10800,1,4,0)
 ;;=4^D75.9
 ;;^UTILITY(U,$J,358.3,10800,2)
 ;;=^5002393
 ;;^UTILITY(U,$J,358.3,10801,0)
 ;;=R97.1^^47^521^26
 ;;^UTILITY(U,$J,358.3,10801,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10801,1,3,0)
 ;;=3^Elevated Cancer Antigen 125
 ;;^UTILITY(U,$J,358.3,10801,1,4,0)
 ;;=4^R97.1
 ;;^UTILITY(U,$J,358.3,10801,2)
 ;;=^5019747
 ;;^UTILITY(U,$J,358.3,10802,0)
 ;;=R97.0^^47^521^27
 ;;^UTILITY(U,$J,358.3,10802,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10802,1,3,0)
 ;;=3^Elevated Carcinoembryonic Antigen
 ;;^UTILITY(U,$J,358.3,10802,1,4,0)
 ;;=4^R97.0
 ;;^UTILITY(U,$J,358.3,10802,2)
 ;;=^5019746
 ;;^UTILITY(U,$J,358.3,10803,0)
 ;;=R74.0^^47^521^28
 ;;^UTILITY(U,$J,358.3,10803,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10803,1,3,0)
 ;;=3^Elevated Liver Function Test
 ;;^UTILITY(U,$J,358.3,10803,1,4,0)
 ;;=4^R74.0
 ;;^UTILITY(U,$J,358.3,10803,2)
 ;;=^5019565
 ;;^UTILITY(U,$J,358.3,10804,0)
 ;;=R97.2^^47^521^29
 ;;^UTILITY(U,$J,358.3,10804,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10804,1,3,0)
 ;;=3^Elevated PSA
 ;;^UTILITY(U,$J,358.3,10804,1,4,0)
 ;;=4^R97.2
 ;;^UTILITY(U,$J,358.3,10804,2)
 ;;=^5019748
 ;;^UTILITY(U,$J,358.3,10805,0)
 ;;=D72.1^^47^521^30
 ;;^UTILITY(U,$J,358.3,10805,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10805,1,3,0)
 ;;=3^Eosinophilia
 ;;^UTILITY(U,$J,358.3,10805,1,4,0)
 ;;=4^D72.1
 ;;^UTILITY(U,$J,358.3,10805,2)
 ;;=^41173
 ;;^UTILITY(U,$J,358.3,10806,0)
 ;;=R73.09^^47^521^31
 ;;^UTILITY(U,$J,358.3,10806,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10806,1,3,0)
 ;;=3^Glucose,Abnormal (HgbA1c)
 ;;^UTILITY(U,$J,358.3,10806,1,4,0)
 ;;=4^R73.09
 ;;^UTILITY(U,$J,358.3,10806,2)
 ;;=^5019563
 ;;^UTILITY(U,$J,358.3,10807,0)
 ;;=R58.^^47^521^32
 ;;^UTILITY(U,$J,358.3,10807,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10807,1,3,0)
 ;;=3^Hemorrhage NEC
 ;;^UTILITY(U,$J,358.3,10807,1,4,0)
 ;;=4^R58.
 ;;^UTILITY(U,$J,358.3,10807,2)
 ;;=^5019528
 ;;^UTILITY(U,$J,358.3,10808,0)
 ;;=E88.09^^47^521^33
 ;;^UTILITY(U,$J,358.3,10808,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10808,1,3,0)
 ;;=3^Hypoalbuminemia NEC
 ;;^UTILITY(U,$J,358.3,10808,1,4,0)
 ;;=4^E88.09
 ;;^UTILITY(U,$J,358.3,10808,2)
 ;;=^5003027
 ;;^UTILITY(U,$J,358.3,10809,0)
 ;;=D70.9^^47^521^34
 ;;^UTILITY(U,$J,358.3,10809,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10809,1,3,0)
 ;;=3^Neutropenia,Unspec
 ;;^UTILITY(U,$J,358.3,10809,1,4,0)
 ;;=4^D70.9
 ;;^UTILITY(U,$J,358.3,10809,2)
 ;;=^334186
 ;;^UTILITY(U,$J,358.3,10810,0)
 ;;=D72.819^^47^521^35
 ;;^UTILITY(U,$J,358.3,10810,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10810,1,3,0)
 ;;=3^White Blood Cell Count,Decreased,Unspec
 ;;^UTILITY(U,$J,358.3,10810,1,4,0)
 ;;=4^D72.819
 ;;^UTILITY(U,$J,358.3,10810,2)
 ;;=^5002376
 ;;^UTILITY(U,$J,358.3,10811,0)
 ;;=D72.829^^47^521^36
 ;;^UTILITY(U,$J,358.3,10811,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10811,1,3,0)
 ;;=3^White Blood Cell Count,Elevated,Unspec
